关键词: ABCA1 CH25H CYP7B1 FLS LXR cholesterol hydroxylase interleukin osteoarthritis phospholipids synovial fibroblasts

Mesh : ATP Binding Cassette Transporter 1 / genetics Benzoates / pharmacology Benzylamines / pharmacology Cells, Cultured Cytochrome P450 Family 7 / genetics Gene Expression Regulation / drug effects Humans Interleukin-1beta / pharmacology Liver X Receptors / genetics Osteoarthritis / genetics metabolism Phospholipids / metabolism Steroid Hydroxylases / genetics Synovial Fluid / cytology drug effects metabolism Synoviocytes / cytology drug effects metabolism

来  源:   DOI:10.3390/ijms23052409   PDF(Pubmed)

Abstract:
(1) Background: Synovial fluid (SF) from knee joints with osteoarthritis (OA) has increased levels of phospholipids (PL). We have reported earlier that TGF-ß and IGF-1 stimulate fibroblast-like synoviocytes (FLS) to synthesize increased amounts of PLs. The current study examined whether IL-1ß induces the release of PLs in FLS and the underlying mechanism. (2) Methods: Cultured human OA FLS were treated with IL-1ß alone and with pathway inhibitors or with synthetic liver X receptor (LXR) agonists. Cholesterol hydroxylases, ABC transporters, apolipoproteins (APO), LXR, sterol regulatory binding proteins (SREBPs), and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) were analyzed by RT-PCR, Western blot, and ELISA. The release of radiolabeled PLs from FLS was determined, and statistical analysis was performed using R (N = 5-9). (3) Results: Like synthetic LXR agonists, IL-1ß induced a 1.4-fold greater release of PLs from FLS. Simultaneously, IL-1ß upregulated the level of the PL transporter ABCA1 and of cholesterol hydroxylases CH25H and CYP7B1. IL-1ß and T0901317 stimulated the expression of SREBP1c, whereas only T0901317 enhanced SREBP2, HMGCR, APOE, LXRα, and ABCG1 additionally. (4) Conclusions: IL-1ß partially controls PL levels in OA-SF by affecting the release of PLs from FLS. Our data show that IL-1ß upregulates cholesterol hydroxylases and thus the formation of oxysterols, which, as natural agonists of LXR, increase the level of active ABCA1, in turn enhancing the release of PLs.
摘要:
(1)背景:骨关节炎(OA)膝关节滑液(SF)的磷脂(PL)水平升高。我们之前报道过TGF-β和IGF-1刺激成纤维细胞样滑膜细胞(FLS)合成的PLs量增加。目前的研究检查了IL-1β是否诱导FLS中PL的释放及其潜在机制。(2)方法:用单独的IL-1β和途径抑制剂或用合成的肝X受体(LXR)激动剂处理培养的人OAFLS。胆固醇羟化酶,ABC运输商,载脂蛋白(APO),LXR,甾醇调节结合蛋白(SREBPs),和3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCR)的RT-PCR分析,蛋白质印迹,和ELISA。确定了放射性标记的PL从FLS的释放,使用R(N=5-9)进行统计分析。(3)结果:像合成的LXR激动剂,IL-1β诱导PLs从FLS释放1.4倍。同时,IL-1β上调PL转运体ABCA1和胆固醇羟化酶CH25H和CYP7B1的水平。IL-1β和T0901317刺激SREBP1c的表达,而只有T0901317增强了SREBP2,HMGCR,APOE,LXRα,和ABCG1另外。(4)结论:IL-1β通过影响从FLS释放PL来部分控制OA-SF中的PL水平。我们的数据显示,IL-1β上调胆固醇羟化酶,从而形成氧固醇,which,作为LXR的天然激动剂,增加活性ABCA1的水平,进而增强PLs的释放。
公众号